HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 63 filers reported holding HARPOON THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,000 | -85.6% | 16,954 | -70.8% | 0.00% | – |
| Q2 2022 | $111,000 | -11.9% | 58,154 | +129.6% | 0.00% | – |
| Q1 2022 | $126,000 | -43.5% | 25,333 | -14.1% | 0.00% | – |
| Q4 2021 | $223,000 | -55.8% | 29,487 | -2.8% | 0.00% | -100.0% |
| Q4 2020 | $504,000 | +32.3% | 30,342 | +35.2% | 0.00% | 0.0% |
| Q3 2020 | $381,000 | – | 22,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 3,156,699 | $15,689,000 | 7.73% |
| MPM ASSET MANAGEMENT LLC | 3,131,388 | $15,563,000 | 5.32% |
| MPM BioImpact LLC | 3,196,707 | $15,888,000 | 4.26% |
| ACUTA CAPITAL PARTNERS, LLC | 497,500 | $2,473,000 | 1.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 151,445 | $2,771,000 | 0.62% |
| Orbimed Advisors | 3,039,508 | $15,106,000 | 0.24% |
| Artal Group S.A. | 1,000,000 | $4,970,000 | 0.21% |
| Cormorant Asset Management, LP | 540,600 | $2,687,000 | 0.21% |
| DAFNA Capital Management LLC | 105,163 | $523,000 | 0.14% |
| Ikarian Capital, LLC | 117,009 | $582,000 | 0.08% |